Tag: Links

What would happen if we allowed drug importation? An analogy from the European PC market.   Infant deaths in the US on the rise.  14 year-old invests cancer-fighting soap. UK firms to consider private health insurance? Is the AMA for or against single payer?

Cato approach to health reform. Water quality in rural America. Benefits of vaccinating pregnant mothers. The real cost of weight loss drugs. Health care worker burnout.

Independent pharmacies view of PBMs. Techno-Optimist Manifesto. Assigning homework with ChatGPT. Honest aging. International travel and the spread of COVID. Do Tobacco-21 laws work?

Chemotherapy shortages…and a solution? FTI Healthcare Q3 in review. Walgreens dives into telehealth. Who profits most from America’s baffling health-care system? Showtime!

FDA’s START program for gene therapies for rare disease. Impact of retirement on health behaviors. COVID impact on health care workers: reduced altruism? ICER solution to IRA’s elimination of QALYs? evLYG. Ghost therapists. Interview with Katalin Karikó.

ICER’s reference case. Digital therapeutics: What the US can learn from Europe. Digital clinical trials in mental health. What happens to health programs if the government shuts down? Medical debt in the US.

Biosimilar “skinny labels” Expensive generics? EU to ban payment for milk, sperm and blood Google Health on AI. Victor Fuchs has passed away..

Excess mortality in China after ending “Zero COVID” Responsiveness to private health insurance subsidies among the elderly. power=0.06 New COVID vaccines for all. ChatGPT made zero “grossly inaccurate” statements when presented with a standard set of eye complaints.

CMS pushing an all-payer model? The real secret to blue zones. New approaches to treating pain. COVID excess deaths by political party. “We have a specialty-driven system. Primary care is seen as a thankless, undesirable backwater.”

Cost sharing analogy: “hydrologist charges travelers high prices for well water” ABCD. AI-generated Narx Score. Does AI already drive safer than humans? FDA: protector or obstacle?